Cargando…

Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest

Objective  This study evaluated the risk of the hereditary breast and ovarian cancer (HBOC) syndrome in patients with breast cancer by using the Family History Screening 7 (FHS-7) tool, a validated low-cost questionnaire with high sensitivity able to screen the HBOC risk in the population. Methods  ...

Descripción completa

Detalles Bibliográficos
Autores principales: Moura, Juliana Batista de, Ghedin, Carla Camila, Takakura, Érika Tomie, Scandolara, Thalita Basso, Rech, Daniel, Panis, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183857/
https://www.ncbi.nlm.nih.gov/pubmed/34547796
http://dx.doi.org/10.1055/s-0041-1733998
_version_ 1785042045657677824
author Moura, Juliana Batista de
Ghedin, Carla Camila
Takakura, Érika Tomie
Scandolara, Thalita Basso
Rech, Daniel
Panis, Carolina
author_facet Moura, Juliana Batista de
Ghedin, Carla Camila
Takakura, Érika Tomie
Scandolara, Thalita Basso
Rech, Daniel
Panis, Carolina
author_sort Moura, Juliana Batista de
collection PubMed
description Objective  This study evaluated the risk of the hereditary breast and ovarian cancer (HBOC) syndrome in patients with breast cancer by using the Family History Screening 7 (FHS-7) tool, a validated low-cost questionnaire with high sensitivity able to screen the HBOC risk in the population. Methods  Women diagnosed with breast cancer ( n  = 101) assisted by the Unified Health System at the 8th Regional Health Municipal Office of the state of Paraná answered the FHS-7, and the results were analyzed using IBM SPSS Statistics for Windows, Version 25.0. software (IBM Corp., Armonk, NY, USA). Results  The risk of HBOC was 19.80% ( n  = 20). Patients at risk exhibited aggressive tumor characteristics, such as high-grade tumors (30%), presence of angiolymphatic emboli (35%), and premenopausal at diagnosis (50%). Significant associations between the prevalence of high-grade tumors were observed in women younger than 50 years at diagnosis with HBOC ( p  = 0.003). Conclusion  Our findings suggest a possible family inheritance associated with worse clinical features in women with breast cancer in this population, indicating that HBOC investigation can be initially performed with low-cost instruments such as FHS-7.
format Online
Article
Text
id pubmed-10183857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Revinter Publicações Ltda.
record_format MEDLINE/PubMed
spelling pubmed-101838572023-07-27 Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest Moura, Juliana Batista de Ghedin, Carla Camila Takakura, Érika Tomie Scandolara, Thalita Basso Rech, Daniel Panis, Carolina Rev Bras Ginecol Obstet Objective  This study evaluated the risk of the hereditary breast and ovarian cancer (HBOC) syndrome in patients with breast cancer by using the Family History Screening 7 (FHS-7) tool, a validated low-cost questionnaire with high sensitivity able to screen the HBOC risk in the population. Methods  Women diagnosed with breast cancer ( n  = 101) assisted by the Unified Health System at the 8th Regional Health Municipal Office of the state of Paraná answered the FHS-7, and the results were analyzed using IBM SPSS Statistics for Windows, Version 25.0. software (IBM Corp., Armonk, NY, USA). Results  The risk of HBOC was 19.80% ( n  = 20). Patients at risk exhibited aggressive tumor characteristics, such as high-grade tumors (30%), presence of angiolymphatic emboli (35%), and premenopausal at diagnosis (50%). Significant associations between the prevalence of high-grade tumors were observed in women younger than 50 years at diagnosis with HBOC ( p  = 0.003). Conclusion  Our findings suggest a possible family inheritance associated with worse clinical features in women with breast cancer in this population, indicating that HBOC investigation can be initially performed with low-cost instruments such as FHS-7. Thieme Revinter Publicações Ltda. 2021-09-21 /pmc/articles/PMC10183857/ /pubmed/34547796 http://dx.doi.org/10.1055/s-0041-1733998 Text en Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Moura, Juliana Batista de
Ghedin, Carla Camila
Takakura, Érika Tomie
Scandolara, Thalita Basso
Rech, Daniel
Panis, Carolina
Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title_full Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title_fullStr Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title_full_unstemmed Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title_short Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
title_sort hereditary breast and ovarian cancer screening syndrome profile in women diagnosed with breast cancer from paraná state southwest
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183857/
https://www.ncbi.nlm.nih.gov/pubmed/34547796
http://dx.doi.org/10.1055/s-0041-1733998
work_keys_str_mv AT mourajulianabatistade hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest
AT ghedincarlacamila hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest
AT takakuraerikatomie hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest
AT scandolarathalitabasso hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest
AT rechdaniel hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest
AT paniscarolina hereditarybreastandovariancancerscreeningsyndromeprofileinwomendiagnosedwithbreastcancerfromparanastatesouthwest